A group of Arizona-based research institutions has won a $5 million grant to help advance scientific understanding, treatment, and prevention of Alzheimer’s disease by developing a public molecular data resource. The NOMIS Foundation, a private Swiss foundation supporting insight-driven scientific endeavors across all disciplines, has awarded the grant to the…

GNS Healthcare, a provider of analytic solutions to pharmaceutical and health plan customers, said it has raised an additional $6 million in equity toward further development of its Reverse Engineering & Forward Simulation (REFS) causal machine learning and simulation platform and solutions. The equity was raised from Amgen Ventures, Amgen’s…

Beset with losses in the year since it went public, NantHealth plans to cut about one-third of its workforce—300 jobs—through layoffs and transfers of employees to one of its investors, Allscripts Healthcare Solutions, which will buy some of the company’s assets. NantHealth—a personalized healthcare company founded by Patrick Soon-Shiong, M.D.—did…

IBM Watson Health and Quest Diagnostics have announced the launch of a precision medicine diagnostics service for cancer that marks the broadest application of the Watson technology for clinical decision support to date. The service, dubbed IBM Watson Genomics from Quest Diagnostics, will pair gene sequencing with cognitive computing—supplemented by…

Biodata gold is all around us, but it is hard to find, distributed as it is in traces throughout a vast biodata landscape, one that has scarcely been explored properly, even as it continues to be reshaped by next-generation sequencing, the effects of which are, well, tectonic. Thus far, biodata…

Contract genomics organization WuXi NextCODE has closed on a $75 million Series B financing from existing investors and partners, with plans to accelerate the growth of its global genomic data platform. Temasek Holdings, a Singapore state-owned investment firm; and Yunfeng Capital, a Chinese private equity firm co-founded by billionaire Alibaba…

Estimates vary as much as the applications of technology when it comes to just how much the liquid biopsy market will grow over the next few years. During March alone, Market Research Future projected no less than a $450 billion market by 2022, based on CAGR of 21.6%, while RNCOS…

The department of pathology at the Icahn School of Medicine at Mount Sinai Hospital recently launched  the Center for Computational and Systems Pathology, with the goal of revolutionizing pathology practice via the use of advanced computer science and mathematical techniques coupled with cutting-edge microscope technology and artificial intelligence. The academic…

Selah Genomics, a subsidiary of EKF Diagnostics, entered an 18 month collaboration with Greenville Health System (GHS), DecisionQ, and Becton Dickinson and Company (BD). The goal of the alliance is to unite clinical annotations with next-generation sequencing (NGS) technology and artificial intelligence-based algorithms in hope of improving clinical decision making…

Researchers have developed a deep learning tool that predicts a patient’s 10-year risk of death from a heart attack or stroke using a single X-ray. Results of the study were presented this week at the annual meeting of the Radiological Society of North America (RSNA). The team’s CXR-CVD risk model performed similarly…

U.S. researchers have used machine learning to predict the effectiveness of multi-drug treatment combinations for tuberculosis (TB), which could help in the design of new therapy regimens. By examining study data from TB drug pairs in vitro, they were able to predict how three or four drugs could affect treatment…

AI pathology specialist PathAI has announced a multi-year expanded collaboration agreement with Bristol Myers Squibb. The initial work within this extended agreement will focus on key translational research in oncology, fibrosis, and immunology, with an overall goal to forward these into clinical trials. PathAI develops quantitative pathology algorithms for drug discovery and development.…

San Mateo, Calif.-based BigHat Biosciences, a developer of safer antibody therapies leveraging machine learning and synthetic biology, announced today the closing of a $75 million Series B funding round led by venture capital firm Section 32. The new investment brings BigHat’s total raised to $100 million and the additional capital…

People who may be stroke-prone because of genetics can lower their risk by as much as 43% by adopting a healthy cardiovascular lifestyle, according to new research led by UTHealth Houston, which was published today in the Journal of the American Heart Association. The study included 11,568 adults from ages 45…

Researchers from the Physical Intelligence Department at the Max Planck Institute for Intelligent Systems in Stuttgart, Germany, have created bacterial microbots they hope will one day deliver anti-cancer drugs directly to tumors. The Escherichia coli bacteria are loaded with magnetic nanoparticles that can be used to control target localization and…